Browse the evidence

Pulsatile or intermittent administration of insulin minimizes desensitization and improves glucose utilization compared to continuous insulin exposure.

If you use insulin, mimicking your body's natural pulse-like release (rather than a constant drip) might work better with less insulin. This suggests that advanced delivery methods or timing strategies could improve effectiveness.

Biological adaptive mechanisms resist weight loss, making long-term maintenance of weight loss difficult without continuous intervention.

Expect your body to fight back after weight loss. This is a biological adaptation, not a personal failure. You will likely need to maintain a slightly higher activity level or lower intake than before to keep the weight off.

Metformin use is associated with a reduced incidence of hepatocellular carcinoma in patients with type 2 diabetes, whereas sulfonylurea or insulin use may increase risk.

If you have type 2 diabetes, talk to your doctor about whether metformin is the right choice for you. Research suggests that metformin may lower your risk of liver cancer compared to other diabetes medications like insulin or sulfonylureas.

Statin use is associated with a reduced incidence of hepatocellular carcinoma in patients with NAFLD.

If you have fatty liver disease, ask your doctor if a statin is appropriate for you. Studies suggest that statins may lower your risk of liver cancer in addition to helping with cholesterol and cardiovascular health.

Dietary palmitic acid intake does not significantly increase tissue palmitic acid levels because endogenous de novo lipogenesis (DNL) compensates by reducing synthesis, maintaining homeostasis under normal conditions.

If you are metabolically healthy, eating palmitic acid (found in palm oil, meat, dairy) does not automatically raise your body's palmitic acid levels. Your body compensates by making less internally. However, this balance breaks down if you have obesity, insulin resistance, or eat too many sugars, which force your body to overproduce fat.

In humans, endogenous leptin does not prevent obesity because obese individuals develop resistance to its effects, primarily due to impaired blood-brain barrier transport and intracellular signaling inhibition.

Your body's natural weight-control hormone (leptin) is present in high amounts but isn't working effectively due to resistance. This is a common physiological state in obesity, not a personal failure. While leptin itself isn't a magic bullet for weight loss in this state, understanding this resistance highlights why simple caloric restriction often triggers strong hunger signals (as leptin drops), making long-term management challenging without addressing the underlying energy balance.

Leptin functions primarily as a starvation signal to conserve energy during caloric deficit, rather than as a long-term regulator of body weight in humans.

When you lose weight, your leptin levels drop faster than your fat mass, signaling 'starvation' to your brain. This triggers hunger and slows metabolism to protect your energy stores. This is a normal survival mechanism, not a failure. Recognizing this helps explain why weight loss can become difficult over time and why sustainable habits are key to managing these hormonal signals.

Selenium intake exhibits extreme variability based on soil geology and plant species, making it difficult to define a single optimal intake level without considering specific health contexts and selenium species.

Do not assume a standard selenium supplement dose is optimal for you. Your selenium needs depend heavily on where your food is grown (soil content), what type of selenium it is (e.g., selenomethionine vs. selenite), and your specific health conditions. If you live in a low-selenium region or have specific health risks, consult a professional to determine if you need more, less, or no supplementation, as both deficiency and toxicity are possible.

Obesity is associated with increased expression of PPAR-gamma2 mRNA in human adipose tissue, with levels and the PPAR-gamma2/PPAR-gamma1 ratio positively correlating with BMI.

This research highlights that obesity involves a molecular upregulation of PPAR-gamma2, a key driver of fat cell formation. This suggests that the body's molecular machinery actively promotes fat storage in obesity, potentially making weight management biologically challenging. Understanding this mechanism underscores why simple caloric restriction might trigger compensatory molecular responses (like the rebound in PPAR-gamma2 seen during weight maintenance).

During prolonged low-intensity exercise (4 hours at 30% VO2max), blood glucose levels fall because hepatic glucose output fails to keep pace with augmented glucose utilization by working muscles, leading to significant liver glycogen depletion.

If you exercise for long durations (over an hour) at a moderate pace, expect your blood sugar to drop as your body depletes liver glycogen. This is a normal metabolic shift, not a failure. Ensure you are well-fed beforehand, but be aware that your body will increasingly rely on fat and gluconeogenesis as glycogen runs low.

During prolonged low-intensity exercise, the relative contribution of free fatty acids (FFA) to total oxygen metabolism in working muscles increases progressively, eventually exceeding the contribution of glucose.

For long, slow workouts, your body naturally shifts to burning more fat as time goes on. You don't need to force-feed yourself carbohydrates during these sessions; your body will access stored fat efficiently.

Prolonged exercise stimulates hepatic gluconeogenesis, with an increasing fraction of glucose output derived from blood-borne precursors like lactate, glycerol, and amino acids (especially alanine) as exercise continues.

Your liver makes new glucose from other substances (like amino acids and glycerol) during long exercise. This is a normal process that helps maintain blood sugar when glycogen runs low.

Exposure to dim light at night (≥5 lux) increases body mass and impairs glucose tolerance in nocturnal rodents by shifting the timing of food intake to the inactive light phase, despite total caloric intake remaining unchanged.

If you are exposed to light at night (e.g., bedroom lights, screens), try to avoid eating during those hours. Even if you don't eat more total food, eating at the 'wrong' time (when you should be sleeping) can lead to weight gain and poorer blood sugar control. Align your eating window with your active, light-exposed hours.

Gut microbiome composition has little to no significant effect on LDL cholesterol or Total Cholesterol levels.

Focusing on gut health may not be the primary strategy for lowering LDL cholesterol. While it may help with triglycerides and HDL, LDL levels appear largely independent of microbiome composition in this study.

Consumption of theabrownin, a pigment in Pu-erh tea, lowers serum and hepatic cholesterol and triglycerides by suppressing bile salt hydrolase (BSH) activity in gut microbiota, which increases ileal conjugated bile acids and inhibits the intestinal FXR-FGF15 signaling pathway, thereby stimulating hepatic bile acid synthesis and excretion.

Drinking Pu-erh tea (specifically the fermented variety rich in theabrownin) can help lower cholesterol and triglycerides. This works not by suppressing appetite, but by changing gut bacteria to reduce bile acid breakdown, which signals the liver to burn more cholesterol. A typical effective dose in the study was roughly 300ml of strong Pu-erh tea twice daily for humans, or equivalent purified theabrownin supplementation.

Classification of dietary fiber by water solubility is an unreliable predictor of physiological effects, as solubility does not directly correlate with fermentability or short-chain fatty acid (SCFA) profiles.

Do not choose foods based on whether they are 'soluble' or 'insoluble' fiber. This classification is scientifically flawed for predicting health benefits. Instead, eat a variety of fiber-rich whole foods (vegetables, fruits, whole grains, legumes) to ensure you get a mix of physiological effects.

High-molecular-weight polysaccharides (>300 kDa) from Hirsutella sinensis mycelium reduce diet-induced obesity and metabolic disorders in mice by selectively enriching the gut bacterium Parabacteroides goldsteinii.

This research suggests that consuming high-molecular-weight polysaccharides from Hirsutella sinensis (a medicinal fungus) may help manage weight and metabolic health by feeding beneficial gut bacteria, specifically Parabacteroides goldsteinii. In mice, this led to a 50% reduction in weight gain on a high-fat diet. While promising, this is an animal study. For humans, this implies that prebiotic fibers that support specific gut bacteria might be beneficial for metabolic health, but direct supplementation with this specific fungal fraction is not yet a standard human treatment.

Oral administration of live Parabacteroides goldsteinii reduces obesity, improves insulin sensitivity, and enhances thermogenesis in high-fat diet-fed mice.

This study suggests that Parabacteroides goldsteinii is a beneficial gut bacterium that can help reduce obesity and improve metabolic health. While you cannot currently buy this specific strain as a commercial probiotic supplement, the findings highlight the importance of supporting beneficial gut bacteria through diet (prebiotics) to potentially improve metabolic health.

Long sleep duration is NOT significantly associated with incident hypertension, and evidence for depression and dyslipidemia is insufficient.

Do not assume that sleeping long hours will cause high blood pressure. This study found no significant link between long sleep and hypertension, unlike its links to heart disease and mortality.

There is a linear, dose-response relationship between longer sleep duration and increased mortality risk, with significant risk increasing at sleep durations >9.5 hours.

Your risk of mortality increases linearly as you sleep more. The data suggests significant risk begins to appear when you sleep more than 9.5 hours. Sticking to 7-9 hours minimizes this specific risk.

Obesity development is driven by hypothalamic inflammation and insulin/leptin resistance, where peripheral saturated fatty acids cross the blood-brain barrier to trigger microglial activation and ER stress, impairing the ability of hypothalamic neurons to regulate appetite and energy expenditure.

If you are struggling with weight gain despite diet efforts, recognize that high-fat diets can biologically alter brain signaling (insulin/leptin resistance) to promote hunger. This is not a character flaw but a physiological response to specific dietary patterns.

Obesity is associated with a gut microbiota composition characterized by a higher Firmicutes-to-Bacteroidetes ratio and an increased capacity for energy harvest, which contributes to host adiposity.

Your gut bacteria may be more efficient at extracting energy from food than those of lean individuals, potentially contributing to weight gain. While you cannot directly 'eat' a new microbiome, the paper suggests that weight loss and dietary changes can alter this composition, potentially reducing this efficiency.

Maternal vitamin B12 deficiency combined with high folate status during pregnancy programs offspring for increased adiposity and insulin resistance by age 6.

For pregnant women, ensuring adequate Vitamin B12 is as critical as folate. In populations with high vegetarianism or low B12 intake, high-dose folic acid supplementation without B12 correction may potentially increase the child's risk of metabolic issues like insulin resistance. Prioritize B12 status alongside folate.

High maternal erythrocyte folate concentrations during pregnancy are associated with increased offspring adiposity (fat mass and body fat percentage) at 6 years, independent of birth weight.

Monitor maternal folate levels. While folate is essential, extremely high levels in the context of B12 deficiency may contribute to offspring adiposity. Ensure a balanced intake rather than excessive supplementation.